Sanctuary Advisors LLC Raises Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sanctuary Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,166 shares of the exchange traded fund’s stock after acquiring an additional 1,711 shares during the period. Sanctuary Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,460,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Envestnet Portfolio Solutions Inc. bought a new position in shares of SPDR S&P Biotech ETF in the second quarter worth about $290,000. Atria Wealth Solutions Inc. raised its stake in SPDR S&P Biotech ETF by 56.1% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock worth $1,539,000 after acquiring an additional 5,962 shares during the period. &PARTNERS lifted its holdings in SPDR S&P Biotech ETF by 8.4% during the second quarter. &PARTNERS now owns 5,939 shares of the exchange traded fund’s stock valued at $551,000 after purchasing an additional 460 shares in the last quarter. Aries Wealth Management bought a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $234,000. Finally, MinichMacGregor Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 2.1% in the second quarter. MinichMacGregor Wealth Management LLC now owns 31,194 shares of the exchange traded fund’s stock worth $2,892,000 after purchasing an additional 640 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $91.28 on Friday. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company’s fifty day moving average price is $97.71 and its 200-day moving average price is $97.11. The company has a market capitalization of $6.96 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.